Metaclazepam: Difference between revisions
CSV import |
No edit summary |
||
| Line 1: | Line 1: | ||
Metaclazepam, marketed under the brand name [[Talis]], belongs to the class of drugs known as [[benzodiazepine]] derivatives. Specifically, it is identified as a relatively selective [[anxiolytic]], which implies it primarily counteracts anxiety without producing significant sedative or muscle-relaxant effects commonly associated with other benzodiazepines. | Metaclazepam, marketed under the brand name [[Talis]], belongs to the class of drugs known as [[benzodiazepine]] derivatives. Specifically, it is identified as a relatively selective [[anxiolytic]], which implies it primarily counteracts anxiety without producing significant sedative or muscle-relaxant effects commonly associated with other benzodiazepines. | ||
[[File:Metaclazepam.svg|Metaclazepam|thumb]] | |||
=== Pharmacology === | === Pharmacology === | ||
Metaclazepam undergoes metabolic processes in the body to produce its primary active metabolite, [[N-desmethylmetaclazepam]]. There has been no observed significant difference in the metabolism of metaclazepam between younger and older individuals, suggesting age doesn't considerably alter its pharmacokinetic profile. | Metaclazepam undergoes metabolic processes in the body to produce its primary active metabolite, [[N-desmethylmetaclazepam]]. There has been no observed significant difference in the metabolism of metaclazepam between younger and older individuals, suggesting age doesn't considerably alter its pharmacokinetic profile. | ||
| Line 21: | Line 21: | ||
* [[Pharmacokinetics]] | * [[Pharmacokinetics]] | ||
{{pharma-stub}} | {{pharma-stub}} | ||
{{Benzodiazepines}} | |||
{{GABAAR PAMs}} | |||
[[Category:Benzodiazepines]] | |||
[[Category:2-Chlorophenyl compounds]] | |||
[[Category:Ethers]] | |||
[[Category:Bromoarenes]] | |||
Latest revision as of 14:43, 31 March 2025
Metaclazepam, marketed under the brand name Talis, belongs to the class of drugs known as benzodiazepine derivatives. Specifically, it is identified as a relatively selective anxiolytic, which implies it primarily counteracts anxiety without producing significant sedative or muscle-relaxant effects commonly associated with other benzodiazepines.
Pharmacology[edit]
Metaclazepam undergoes metabolic processes in the body to produce its primary active metabolite, N-desmethylmetaclazepam. There has been no observed significant difference in the metabolism of metaclazepam between younger and older individuals, suggesting age doesn't considerably alter its pharmacokinetic profile.
Therapeutic Efficacy[edit]
Compared to other benzodiazepines such as bromazepam and diazepam, metaclazepam displays slightly enhanced efficacy as an anxiolytic. In terms of dose equivalency, a 15 mg dose of metaclazepam is analogous to a 4 mg dose of bromazepam.
Drug Interactions[edit]
When combined with alcohol, metaclazepam may exhibit additive sedative-hypnotic effects. This interaction is a crucial consideration for patients and clinicians, as the co-ingestion could elevate the risk of overdose or lead to impaired cognition and motor functions.
Side Effects[edit]
Fatigue is a frequently reported side effect when consuming high doses of metaclazepam. Other potential side effects might include drowsiness, dizziness, and impaired coordination.
Special Considerations[edit]
Breastfeeding mothers should exercise caution as metaclazepam and its metabolites have been detected in human breast milk, potentially posing a risk to nursing infants.
See Also[edit]
Benzodiazipines[edit]
- Alprazolam
- Chlordiazepoxide
- Diazepam (Oral)
- Estazolam
- Flurazepam
- Lorazepam
- Midazolam
- Oxazepam
- Quazepam
- Temazepam
- Triazolam
Anticonvulsants Drugs[edit]
